Kisqali ‘Live Longer’ TV Ad Misrepresents Patient-Reported Outcome Data, US FDA Tells Novartis

Untitled letter says advertisement could lead breast cancer patients to believe Kisqali has better overall survival and quality of life than was demonstrated. FDA also criticizes length of time to read claims in superimposed text and competing audio and visual presentations in the TV spot.